Pilot Study of NovoTTF-100A for Recurrent Atypical and Anaplastic Meningioma
A study for patients with progressive meningioma using study device NovoTTF-100A
Sponsor: Memorial Sloan Kettering Cancer Center
Enrolling: Male and Female Patients
IRB Number: AAAO4805
U.S. Govt. ID: NCT01892397
Contact: Teri Kreisl: 212-342-0571 / tnk2109@cumc.columbia.edu
Additional Study Information: The purpose of this study is to find out what effects, good or bad, the experimental device, NovoTTF-100A has on patients with meningioma. This study is being done because currently there are no proveneffective medical treatments for a progressive meningioma that has failed surgery and/or radiation. The NovoTTF-100A System is a portable medical device. It delivers electric fields called TTFields to the brain using transducer arrays which are sticky pads placed on the scalp. TTFields are intended to kill cancer cells..
This study is closed
Investigator
Teri Kreisl, MD
Do You Qualify?
Have you been diagnosed with meningioma? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Teri Kreisl
tnk2109@cumc.columbia.edu
212-342-0571
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE